CE mark given to precision laser system

Article

OptiMedica's Catalys precision laser system has been given the CE mark of approval for corneal incisions.

OptiMedica's Catalys precision laser system has been given the CE mark of approval for corneal incisions.

The system enables the surgeon to conduct precise corneal incisions with accurate orientation, length and depth. Single-plan sideport incisions and self-healing multi-plane cataract incisions can also be performed.

CEO of OptiMedica, Mark J. Forchette, said, "The CE mark approval for corneal incisions is an exciting development that will allow Catalys to bring even more value to the laser cataract procedure. We are thrilled to be able to extend the system’s precision and accuracy benefits to these important surgical steps, as they will further optimize the experience for cataract surgeons and their patients.”

Professor Burkhard Dick, member of OTEurope's Editorial Advisory Board and the first person to use the system, said, "“I believe that Catalys represents the forefront of innovation in laser cataract surgery, and it’s been my pleasure to break new ground by using the system for corneal incisions. It has proven to be a very valuable addition to my practice, and I look forward to continuing to work with OptiMedica to set the new standard in laser cataract surgery.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.